Comparing ConforMIS (CFMS) and Smith & Nephew SNATS (NYSE:SNN)

ConforMIS (NASDAQ: CFMS) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Earnings & Valuation

This table compares ConforMIS and Smith & Nephew SNATS’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
ConforMIS $79.26 million 1.99 -$54.78 million ($1.36) -2.64
Smith & Nephew SNATS $4.68 billion 3.28 $1.32 billion N/A N/A

Smith & Nephew SNATS has higher revenue and earnings than ConforMIS.

Volatility and Risk

ConforMIS has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for ConforMIS and Smith & Nephew SNATS, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConforMIS 0 4 3 0 2.43
Smith & Nephew SNATS 0 4 2 0 2.33

ConforMIS presently has a consensus price target of $8.25, suggesting a potential upside of 129.81%. Given ConforMIS’s stronger consensus rating and higher possible upside, research analysts plainly believe ConforMIS is more favorable than Smith & Nephew SNATS.

Profitability

This table compares ConforMIS and Smith & Nephew SNATS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ConforMIS -72.87% -66.61% -49.87%
Smith & Nephew SNATS N/A N/A N/A

Dividends

Smith & Nephew SNATS pays an annual dividend of $0.61 per share and has a dividend yield of 1.7%. ConforMIS does not pay a dividend. ConforMIS has raised its dividend for 4 consecutive years.

Insider and Institutional Ownership

39.5% of ConforMIS shares are owned by institutional investors. Comparatively, 7.2% of Smith & Nephew SNATS shares are owned by institutional investors. 9.6% of ConforMIS shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

About ConforMIS

ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient’s anatomy. The Company’s iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient’s knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

What are top analysts saying about ConforMIS Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ConforMIS Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit